如果您要报告不良事件或产品投诉,请拨打礼来客户服务中心热线400-828-2059(手机),800-828-2059(座机)
无论糖尿病病程、微血管疾病和 BMI ，度拉糖肽治疗患者 HbA1c下降 ：来自 REWIND 试验的事后分析
返回HbA1c Reduction in Dulaglutide-Treated Patients Irrespective of Duration of Diabetes, Microvascular Disease, and BMI: A Post Hoc Analysis From the REWIND Trial
作者：Anita Y.M. Kwan; Hertzel C. Gerstein ; Jan Basile; Denis Xavier; Juan M. Maldonado; Sohini Raha; Manige Konig 期刊：Diabetes Care卷/期/页码：Volume 45, Issue 345(3):547–554
